NOTCH signaling pathways (NOTCH4, Notch-HLH, Pre-NOTCH processing) were significantly enriched, consistent with [28, 29] NOTCH1 and NOTCH4 promoting stemness, therapy resistance, and aggressive phenotypes particularly in basal-like and triple-negative breast cancers. Here, NOTCH4 is linked to triple-negative breast carcinoma.